1.910USD-1.55%Mkt Cap: 2.78M $P/E: 0.232d ago
Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The…
Industry Peers
Agricultural InputsKey Statistics
Company
Market Cap2.78M $
Enterprise Value-5.96M $
Revenue (TTM)—
Gross Profit2.00K $
Net Income (TTM)-4.00M $
Revenue/Share—
Last Price1.910 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees7
CountryUS
SectorBasic Materials
IndustryAgricultural Inputs
ISIN—
Valuation
P/E (Trailing)0.23
P/E (Forward)—
PEG—
EV/EBITDA1.03
EV/Revenue—
P/S—
P/B1.37
EPS (TTM)7.77
EPS (Forward)—
52W Range
1.4301% of range60.51
52W High60.51 USD
52W Low1.430 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-25.01%
ROA-19.62%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.81M $
CapEx (TTM)14.00K $
FCF Margin—
FCF Yield-232.59%
Net Debt-8.45M $
Net Debt/EBITDA1.47
Balance Sheet
Debt/Equity0.06
Current Ratio3.72
Quick Ratio3.18
Book Value/Sh1.311 USD
Cash/Share6.110 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:7
Split DateApr 8, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.45M
Float835.17K
Insiders21.17%
Institutions4.36%
Short Interest
Short Ratio0.6d
Short % Float4.64%
Short % Out.4.26%
Shares Short61.97K
Short (prev mo.)97.14K
Technical
SMA 503.324 (-42.5%)
SMA 2008.329 (-77.1%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)92.14K
Avg Vol (10d)29.71K
Technical Indicators
RSI (14)39.9
MACD-0.5091
MACD Signal-0.6383
MACD Hist.+0.1292
BB Upper2.563 USD
BB Middle1.957 USD
BB Lower1.350 USD
BB Width62.00%
ATR (14)0.4608 USD
Vol Ratio (20d)0.14x